Matthew Tudball, PhD

Matt completed his PhD in the MRC Integrative Epidemiology Unit at the University of Bristol on a Wellcome Trust studentship. His research focused on the development of novel causal and statistical inference methods, with applications to genetic epidemiology. During his PhD, he spent time at the Statistical Laboratory at the University of Cambridge and completed industry internships in pharma and biotech.

At 5 Prime Sciences, Matt leads the design and implementation of statistical methods underpinning the company's target discovery platform, including tools for disease progression, therapeutic direction of effect, and polypharmacy. He works closely with clients and the broader statistical genetics team to ensure 5PS's methods remain scientifically rigorous and translate into actionable target intelligence for pharma and biotech partners.